Register entry
- Registered sites
- 2
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- Japan
Authorisation
Registered operations
Active ingredient (API) manufacture2
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| FUJIMOTO CHEMICALS CO., LTD. | 1-2-38, Kinrakuji-cho, Amagasaki, Hyogo 6600806, Japan (JPN) | Active ingredient (API) manufacture | 3002806358717836709 |
| FUJIMOTO CHEMICALS CO., LTD. | 1-24, Rinkai-cho, Izumiotsu, Osaka 5950075, Japan (JPN) | Active ingredient (API) manufacture | 3009975775717836717 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | ALECTINIB HYDROCHLORIDE | powder | 10261-2123BULK INGREDIENT |
Neighbours
Registered in the same town
1- Shionogi Pharma Co., Ltd.Amagasaki, JPN
Compare
Comparable companies in Japan
- Sumitomo Pharma Co., Ltd.2 sites · 24 NDC
- TAYCA CORPORATION2 sites · 22 NDC
- SUMITOMO OSAKA CEMENT CO., LTD.2 sites · 6 NDC
- MicroBiopharm Japan Co., Ltd.2 sites · 2 NDC
- Nissui Corporation2 sites · 2 NDC
- UBE Corporation2 sites · 1 NDC
- KATAYAMA SEIYAKUSYO CO., LTD.2 sites · 0 NDC
- NOF CORPORATION2 sites · 0 NDC
- Sucampo Pharma Americas, LLC2 sites · 0 NDC
- Taiho Oncology, Inc.2 sites · 0 NDC
Enquiry
Common questions
- Is FUJIMOTO CHEMICALS CO., LTD. FDA approved?
- FUJIMOTO CHEMICALS CO., LTD. holds 2 FDA-registered establishments in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are FUJIMOTO CHEMICALS CO., LTD.'s drugs manufactured?
- The FDA register lists Amagasaki; Izumiotsu. Registered operations: active ingredient (API) manufacture.
- What drugs does FUJIMOTO CHEMICALS CO., LTD. make?
- 1 product is listed under FUJIMOTO CHEMICALS CO., LTD. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.